Stocks making the biggest moves premarket: Pfizer, Lululemon, Manchester United, Rite Aid and more

  • 📰 CNBC
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

These are the stocks posting the largest moves in premarket trading.

Check out the companies making headlines before the bell. Pfizer , Moderna , BioNTech — Shares of Pfizer dropped 1.3% after the company slashed its full-year revenue guidance by $9 billion, noting waning demand for its Covid treatment and vaccine. Following the guidance cut, Jefferies upgraded Pfizer on Monday, citing an attractive buying opportunity. Vaccine markers Moderna and BioNTech also dropped premarket, losing 4.1% and 5%, respectively. Novavax shed 2.4%.

Rite Aid – Shares tumbled more than 5% premarket and trading was halted after the pharmacy chain on Sunday filed for Chapter 11 bankruptcy protection in New Jersey amid slowing sales, mounting debt and lawsuits related to its alleged part in the nation's opioid epidemic. The company said it reached a deal with creditors on a restructuring plan and appointed Jeffrey Stein as its new CEO to steer the company through it. Lululemon — Shares jumped more than 5% Monday premarket.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stock Market Today: Dow Futures Edge Up; Investors Eye Lululemon, PfizerCharles Schwab is set to report earnings this morning; Middle East is in focus
Source: WSJ - 🏆 98. / 63 Read more »

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Source: ForbesTech - 🏆 318. / 59 Read more »

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting DemandI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Source: Forbes - 🏆 394. / 53 Read more »